Antibody responses to individual proteins of SARS coronavirus and their neutralization activities

[1]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[2]  H. Lehrach,et al.  Protein arrays for gene expression and molecular interaction screening. , 2000, Current opinion in microbiology.

[3]  S. Schreiber,et al.  Printing proteins as microarrays for high-throughput function determination. , 2000, Science.

[4]  D. Cahill,et al.  Protein and antibody arrays and their medical applications. , 2001, Journal of immunological methods.

[5]  Andrea Crisanti,et al.  Antigen microarrays for serodiagnosis of infectious diseases. , 2002, Clinical chemistry.

[6]  K. Büssow,et al.  High-throughput protein arrays: prospects for molecular diagnostics. , 2002, Trends in molecular medicine.

[7]  Obi L. Griffith,et al.  The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.

[8]  J. A. Comer,et al.  A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[9]  Christian Drosten,et al.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[10]  Wuchun Cao,et al.  A complete sequence and comparative analysis of a SARS-associated virus (Isolate BJ01) , 2003, Chinese science bulletin = Kexue tongbao.

[11]  A. Xu,et al.  Profile of specific antibodies to the SARS-associated coronavirus. , 2003, The New England journal of medicine.

[12]  S. Nock,et al.  Recent developments in protein microarray technology. , 2003, Angewandte Chemie.

[13]  H. Perreault,et al.  Mass Spectrometric Characterization of Proteins from the SARS Virus , 2003, Molecular & Cellular Proteomics.

[14]  Christian Drosten,et al.  Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.

[15]  Ruifu Yang,et al.  Antigenicity Analysis of Different Regions of the Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein , 2004, Clinical chemistry.

[16]  M. Zambon,et al.  Cleavage and Serum Reactivity of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein , 2004, The Journal of infectious diseases.

[17]  Yee-Joo Tan,et al.  Antibodies to Severe Acute Respiratory Syndrome (SARS) , 2022 .

[18]  C. Hsiao,et al.  Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus , 2004, FEBS Letters.

[19]  Pei-Jer Chen,et al.  Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA , 2004, Journal of medical virology.

[20]  P. Woo,et al.  Detection of Specific Antibodies to Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein for Serodiagnosis of SARS Coronavirus Pneumonia , 2004, Journal of Clinical Microbiology.

[21]  B. Moss,et al.  Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Michelle M. Packard,et al.  Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice , 2004, Journal of Virology.

[23]  S. Qiu,et al.  An Exposed Domain in the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Induces Neutralizing Antibodies , 2004, Journal of Virology.

[24]  B. Murphy,et al.  Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Lim,et al.  Antibody Response of Patients with Severe Acute Respiratory Syndrome (SARS) Targets the Viral Nucleocapsid , 2004, The Journal of infectious diseases.

[26]  Z. Rao,et al.  Protective humoral responses to severe acute respiratory syndrome-associated coronavirus: implications for the design of an effective protein-based vaccine. , 2004, The Journal of general virology.

[27]  Y. Leo,et al.  Profiles of Antibody Responses against Severe Acute Respiratory Syndrome Coronavirus Recombinant Proteins and Their Potential Use as Diagnostic Markers , 2004, Clinical Diagnostic Laboratory Immunology.

[28]  Y. Wang,et al.  Characterization of the 3a Protein of SARS-associated Coronavirus in Infected Vero E6 Cells and SARS Patients , 2004, Journal of Molecular Biology.